Table 3.
Comparison between percent area of TGF-β1 expression in the submucosa, controls versus CRSwNP patients
|
Submucosa | |||
|---|---|---|---|
| CRSwNP | Control | ||
| 1 |
35.07% |
1 |
20.56% |
| 2 |
12.23% |
2 |
0.00% |
| 3 |
24.66% |
3 |
0.00% |
| 4 |
18.53% |
4 |
0.00% |
| 5 |
19.75% |
5 |
10.80% |
| 6 |
17.15% |
6 |
0.00% |
| 7 |
22.16% |
7 |
0.00% |
| 8 |
25.64% |
8 |
0.00% |
| 9 |
20.26% |
9 |
15.54% |
| 10 |
18.00% |
10 |
15.77% |
| 11 |
44.06% |
11 |
0.00% |
| 12 |
25.82% |
|
|
| 13 |
31,50% |
|
|
| 14 |
34.60% |
|
|
| 15 |
13.17% |
|
|
| 16 |
20.64% |
|
|
| 17 | 11.87% | ||